S. Korfee - Concepedia

Author

S. Korfee

Ruhrlandklinik

Also Known As

S Korfee, S. Korfee, Soenke Korfee, Sönke Korfee

Publications

447

Citations

H-Index

Concepts

All Affiliations

Ruhrlandklinik Peking University Antwerp University Hospital Essen University Hospital AstraZeneca (United Kingdom)

About

S. Korfee is an author at Ruhrlandklinik specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	186
2	Health Sciences	2	2	109
3	Pharmacology	2	2	58
4	Orthopaedics	1	1	13
5	Pathology	1	1	76

S. Korfee

Publications

400

Citations

H-Index

Page 1

	Year	Citations
Prophylactic Cranial Irradiation in Operable Stage IIIA Non–Small-Cell Lung Cancer Treated With Neoadjuvant Chemoradiotherapy: Results From a German Multicenter Randomized Trial Christoph Pöttgen, Wilfried Eberhardt, S. Korfee, Journal of Clinical Oncology	2007	137
Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour Alessandro Marra, Wilfried Eberhardt, Christoph Pöttgen, European Respiratory Journal	2006	77
Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small cell lung cancer (NSCLC): A randomized, double-blind phase III trial (ZODIAC) Roy S. Herbst, Yan Sun, S. Korfee, Journal of Clinical Oncology Surgical OncologyCancer ManagementPathologyPharmacotherapyMay 30	2009	76
Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small cell lung cancer (NSCLC): A randomized, double-blind phase III trial (ZODIAC) Roy S. Herbst, Yi Sun, S. Korfee, Journal of Clinical Oncology PharmacotherapyOverall SurvivalPre-clinical PharmacologySecond-line TreatmentMetronomic Therapy	2009	33
A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumors K. Mross, Heike Richly, N. Schleucher, Annals of Oncology OncologyBay 38-3441MedicineDaily InfusionPharmacotherapy	2004	25
Intensified High-Dose Chemoradiotherapy With Induction Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer—Safety and Toxicity Results Within a Prospective Trial Christoph Pöttgen, Wilfried Eberhardt, Thomas Gauler, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineOncologyToxicity ResultsMetronomic TherapyHigh-dose Chemoradiotherapy	2009	21
Pemetrexed in the treatment of malignant mesothelioma: Results from an expanded access program in Germany Martin Reck, Rolf A. Stahel, Joachim von Pawel, Respiratory Medicine Surgical OncologyMedicineMalignant MesotheliomaSurgeryExpanded Access Program	2009	18
Recurrent schwannoma: Diagnosis with PET/CT Gerald Antoch, Thomas Egelhof, S. Korfee, Neurology Pet-mriDiagnosisClinical AnatomySurgeryRecurrent Schwannoma	2002	13

Page 1